19-48306328-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001364171.2(ODAD1):​c.598-5C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00434 in 1,550,312 control chromosomes in the GnomAD database, including 245 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 137 hom., cov: 31)
Exomes 𝑓: 0.0024 ( 108 hom. )

Consequence

ODAD1
NM_001364171.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00008102
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.34

Publications

3 publications found
Variant links:
Genes affected
ODAD1 (HGNC:26560): (outer dynein arm docking complex subunit 1) This gene encodes a coiled-coil domain-containing protein that is a component of the outer dynein arm docking complex in cilia cells. Mutations in this gene may cause primary ciliary dyskinesia 20. [provided by RefSeq, May 2013]
ODAD1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 20
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-48306328-G-T is Benign according to our data. Variant chr19-48306328-G-T is described in ClinVar as Benign. ClinVar VariationId is 262500.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0763 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD1NM_001364171.2 linkc.598-5C>A splice_region_variant, intron_variant Intron 7 of 15 ENST00000674294.1 NP_001351100.1
ODAD1NM_144577.4 linkc.487-5C>A splice_region_variant, intron_variant Intron 5 of 13 NP_653178.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD1ENST00000674294.1 linkc.598-5C>A splice_region_variant, intron_variant Intron 7 of 15 NM_001364171.2 ENSP00000501363.1

Frequencies

GnomAD3 genomes
AF:
0.0225
AC:
3417
AN:
151996
Hom.:
136
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0784
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00872
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00539
AC:
833
AN:
154490
AF XY:
0.00421
show subpopulations
Gnomad AFR exome
AF:
0.0843
Gnomad AMR exome
AF:
0.00478
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000417
Gnomad OTH exome
AF:
0.00414
GnomAD4 exome
AF:
0.00235
AC:
3292
AN:
1398198
Hom.:
108
Cov.:
30
AF XY:
0.00209
AC XY:
1441
AN XY:
689702
show subpopulations
African (AFR)
AF:
0.0832
AC:
2627
AN:
31566
American (AMR)
AF:
0.00504
AC:
180
AN:
35690
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25158
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35706
South Asian (SAS)
AF:
0.000114
AC:
9
AN:
79204
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49234
Middle Eastern (MID)
AF:
0.00474
AC:
27
AN:
5694
European-Non Finnish (NFE)
AF:
0.000168
AC:
181
AN:
1078000
Other (OTH)
AF:
0.00462
AC:
268
AN:
57946
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
138
276
413
551
689
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0226
AC:
3433
AN:
152114
Hom.:
137
Cov.:
31
AF XY:
0.0223
AC XY:
1657
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0785
AC:
3257
AN:
41480
American (AMR)
AF:
0.00871
AC:
133
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
67984
Other (OTH)
AF:
0.0132
AC:
28
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
156
313
469
626
782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00576
Hom.:
42
Bravo
AF:
0.0252
Asia WGS
AF:
0.00462
AC:
17
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 06, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not provided Benign:2
Mar 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 20 Benign:1
Sep 07, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.024
DANN
Benign
0.50
PhyloP100
-3.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000081
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10416590; hg19: chr19-48809585; API